The Application of Tirofiban in the Endovascular Treatment of Acute Ischemic Stroke: A Meta-Analysis
Conclusions: The application of tirofiban in EVT of AIS may improve functional outcomes and reduce mortality at 3 months. Besides, tirofiban does not seem to increase the risk of symptomatic intracranial hemorrhage and intracranial hemorrhage, either in the anterior or posterior circulation stroke.Cerebrovasc Dis
Source: Cerebrovascular Diseases - Category: Neurology Source Type: research
More News: Databases & Libraries | Hemorrhagic Stroke | Ischemic Stroke | Neurology | Science | Statistics | Stroke | Study